Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis

Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis

This study aimed to compare the efficacy of rituximab versus Cyclophosphamide on active secondary progressive multiple sclerosis (SPMS). The randomized clinical trial was performed from 2015 to 2017 in multiple sclerosis (MS) clinics affiliated to Isfahan MS society (IMSS). Patients were randomized...

Full description

Bibliographic Details
Main Authors: Masoud Etemadifar, Shadi Ghourchian, Nazanin Mahinparvar, Mehri Salari, Fatemeh Etemadifar, Yalda Nikanpour, Shahin Sanaei, Mojtaba Akbari
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-02-01
Series:Acta Medica Iranica
Subjects:
Multiple sclerosis
Rituximab
Cyclophosphamide
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/8096

Internet

https://acta.tums.ac.ir/index.php/acta/article/view/8096

Similar Items